secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2025-12-31T23:59:59+00:00
Accession:  0001012975-25-000992
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed completes Scilex warrant repurchase; receives $28.5M total
-----------------------------------------------------------------

- Scilex repurchased second tranche of 3,370,000 warrants for $14M on Dec 30, 2025.
- Oramed also received a $750,000 option fee for the second tranche.
- Total aggregate proceeds from both tranches and fees equal $28.5M.
- First tranche of 3,130,000 warrants was repurchased for $13M in September 2025.
- Subject warrants had an exercise price of $0.01 per share of Scilex common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000101297525000992/0001012975-25-000992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000101297525000992/ormp-20251230.htm
  HTML page:      https://secwatch.observer/filing/0001012975-25-000992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer